Tourette Syndrome Clinical Trial
Official title:
MEG Study of Altered Sensory Processing in Tourette Syndrome: An Exploration of Sensory Tics
Verified date | September 6, 2007 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will examine brain activity associated with the involuntary urges or uncontrolled
movements, called "tics," experienced by people who have Tourette syndrome (TS). Before
people with TS actually develop a tic, whether it is a movement or a vocal tic (like a cough
or bark), they feel the urge to tic. This study will look at brain activity during the time
of this urge and how brain activity may differ in people with TS and without TS.
Healthy normal volunteers and patients with TS between 14 and 65 years of age may be eligible
for this study. Patients must have sensory tics in the facial region and must experience at
least a moderate premonitory urge. Candidates are screened with a medical history, brief
physical examination, and a questionnaire.
Participants undergo the following procedures:
- Magnetoencephalography (MEG): This test records magnetic field changes produced by brain
activity. During the test, the subjects are seated in the MEG recording room and a cone
containing magnetic field detectors is lowered onto their head. Electrodes (small metal
disks) are placed on both sides of the face near the jaw. The recording may be made
while the subject receives small currents from the electrodes on the jaw. Subjects may
be asked a few questions about what they felt during the procedure.
- Magnetic resonance imaging (MRI): This test uses a strong magnetic field and radio waves
to obtain images of body organs and tissues. During the procedure, the subject lies on a
table that can slide in and out of the scanner-a metal cylinder. Subjects may be asked
to lie still for up to 30 minutes at a time. They can communicate with the staff at any
time during the scan.
- Somatosensory evoked responses: This test examines how sensory information travels form
the nerves to the spinal cord and brain in the nervous system. An electrode placed on
the arm, leg, or face delivers a small electrical stimulus that may tingle and cause a
twitch of a hand, foot, or face muscle. Additional electrodes may sometimes be placed on
the scalp, neck, and over the collarbone to record how the impulse from the stimulus
travels over nerve pathways.
Patients in the study are contacted for follow-up after the study. Follow-up will be
conducted by phone or email, according to the patients' convenience, and will consist of
reaffirming that there were no adverse events.
Status | Completed |
Enrollment | 30 |
Est. completion date | September 6, 2007 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 14 Years to 65 Years |
Eligibility |
- INCLUSION CRITERIA FOR NORMAL VOLUNTEERS: Subjects will be normal volunteers with no history of neurological disorders; they will be screened in the NINDS Movement Disorders Outpatient Clinic, and will have a neurological and physical examination. Subjects will be male or female, in age ranges 14 to 65 years old. INCLUSION CRITERIA FOR PATIENTS: Patients ages 14 to 65 with a clinical diagnosis of tourette syndrome or chronic motor tic disorder as defined by DSM-IV-TR and evaluation of tic severity using the Yale Tic Scale (YGTSS). This criterion will be established by preliminary screening in the NINDS Movement Disorders Outpatient Clinic. Structure Clinical Interview for (DSMIV SCID) will be administered to all subjects to ensure that strict DSM-IV criteria for Tourette syndrome have been met and to assess for possible comorbid psychiatric disorders. Patients with at least moderate premonitory urge, as evaluated with the PUTS. Patients with sensory tics, either bilaterally or unilaterally, in the facial region. EXCLUSION CRITERIA FOR PATIENTS AND NORMAL VOLUNTEERS: Cardiac pacemaker / cardiac or neural defibrillators. Metal fragments in the eyes. Metal plates, pins, or bolts in the head. Any magnetic implantation / implantations made from iron (ferrous products). Hearing problems. Problems using response devices. Subjects younger than 14 or older than 65 years. Subjects with 1 ) major depression, 2) bipolar disorder, or 3) psychotic disorder. Subjects taking benzodiazepines, anti-depressant or neuroleptic medications. Subjects with major acute or chronic illness, or subjects for whom sitting in a still position for an extended period of time would trigger or exacerbate a preexisting condition or cause any undue harm or discomfort. Pregnant women (steroidal hormones have been shown to influence EEG (Rupprecht et al., 2001). Patients with severe head tics or subjects who are unable to hold their head still in a scanner for at least 70 seconds. |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Bliss J. Sensory experiences of Gilles de la Tourette syndrome. Arch Gen Psychiatry. 1980 Dec;37(12):1343-7. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04851678 -
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
|
||
Completed |
NCT02605902 -
Trial to Demonstrate the Efficacy and Safety of Internet-delivered Behavioral Treatment for Adults With Tic Disorders
|
N/A | |
Completed |
NCT04007913 -
Incorporating teleCBIT Into a Hospital-Based Tic Program
|
N/A | |
Completed |
NCT02900144 -
Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)
|
N/A | |
Completed |
NCT02256475 -
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT02216474 -
Brain Stimulation in Movement Disorders
|
N/A | |
Completed |
NCT01329198 -
Brain Stimulation for the Treatment of Tourette Syndrome
|
N/A | |
Terminated |
NCT00952601 -
Pilot Study of the Modified Atkins Diet for Tourette Syndrome
|
Phase 1 | |
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT00206323 -
A Randomized, Placebo-controlled, Tourette Syndrome Study.
|
Phase 3 | |
Completed |
NCT00004376 -
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
|
Phase 3 | |
Completed |
NCT04498364 -
Extinction Learning in Adults With Tourette Syndrome
|
N/A | |
Completed |
NCT00755339 -
Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome
|
||
Completed |
NCT03325010 -
Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
Completed |
NCT01719523 -
Open-Trial of EPI-743 for Adults With Tourette Syndrome
|
Phase 1 | |
Completed |
NCT01702077 -
Neurofeedback for Tourette Syndrome
|
N/A | |
Completed |
NCT00231985 -
Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder
|
Phase 2 | |
Completed |
NCT00206336 -
An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.
|
Phase 3 | |
Terminated |
NCT03732534 -
Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome
|
Phase 2 |